Analyze Biological Data
With Precision and Clarity
From Kaplan-Meier survival curves to Cox Proportional Hazards models, our PhD-level biostatisticians handle every statistical challenge your coursework or research demands. Trusted by students in public health, medicine, and biology programs globally.
Academic Scope
What Biostatistics Actually Covers
Biostatistics is not general math. It is the disciplined application of statistical theory to biological, medical, and public health data — and every subdomain demands its own methods.
In a formal academic context, biostatistics sits at the intersection of probability theory, research methodology, and domain science. The work goes far beyond plugging numbers into formulas. A well-executed biostatistics assignment requires selecting the correct test for your data type, satisfying the assumptions behind that test, interpreting outputs in plain language, and situating findings within the context of the research question. Whether you are enrolled in a Master of Public Health program, a PhD in epidemiology, or studying for the USMLE Step 1, the core statistical reasoning is the same — only the application layer changes.
Our service provides expert support across all of these layers. We assist with research papers requiring quantitative validation, data analysis assignments, and entire dissertation statistical chapters. The four foundational domains below represent the intellectual architecture of the discipline.
Descriptive Biostatistics
Summarizing biological data using numerical and graphical methods. This includes computing incidence rates, prevalence, mortality rates, and central tendency measures in health populations. It is the first step in any analysis — you must know what your data looks like before testing any hypothesis.
Inferential Biostatistics
Drawing conclusions about populations from sample data. Hypothesis testing sits at the center of this domain — testing whether an observed difference in drug efficacy, disease risk, or treatment outcome is statistically meaningful or attributable to chance.
Regression Modeling
Predicting health outcomes and understanding risk relationships across multiple variables simultaneously. Biostatistical regression is more nuanced than its engineering equivalent — confounding, mediation, and interaction are central concerns in every model built on human data.
Survival Analysis
Analyzing time-to-event data where the outcome is not just whether something happened, but when. This is the statistical backbone of clinical trials studying mortality, disease recurrence, and patient follow-up. Censoring — accounting for patients who leave the study — is a defining challenge of this domain.
Services
Core Biostatistical Topics We Cover
Every area below represents a distinct analytical method with its own assumptions, software implementation, and interpretation framework.
Clinical Trials & RCT Design
Designing and analyzing Phase I–IV randomized controlled trials. Randomization schema, allocation concealment, blinding protocols, and ITT vs. per-protocol analysis. We support CONSORT-compliant reporting.
View Nursing Services →Epidemiology & Disease Modeling
Studying disease distribution and determinants in populations. Calculating incidence density ratios, prevalence, attack rates, and measures of association including relative risk and odds ratios. Cohort, case-control, and cross-sectional study designs.
View Public Health Services →ANOVA, MANOVA & Mixed Models
Comparing means across multiple treatment groups simultaneously. One-way, two-way, and repeated-measures ANOVA. Linear mixed models for longitudinal data with random effects when patients are measured repeatedly over time.
Categorical Data Analysis
Analyzing binary and nominal outcomes using Chi-square tests, Fisher’s Exact test, and McNemar’s test for paired data. Contingency table construction, risk difference, and odds ratio estimation with confidence intervals.
Genomics & Bioinformatics
High-dimensional data analysis for biological sequence and expression data. Microarray analysis, RNA-seq differential expression, genome-wide association studies (GWAS), and dimensionality reduction (PCA, t-SNE).
View Biology Services →Non-Parametric Methods
When data violates normality assumptions, non-parametric tests provide valid alternatives. Mann-Whitney U, Wilcoxon Signed-Rank, Kruskal-Wallis, and Spearman correlation for ranked data from small or skewed samples.
View Statistics Services →Power Analysis & Sample Size
Calculating the minimum sample required to detect a clinically meaningful effect at a specified significance level and statistical power. We work across study designs: parallel group, crossover, paired, and equivalence/non-inferiority trials.
Meta-Analysis & Systematic Reviews
Synthesizing evidence across multiple studies. Fixed-effects vs. random-effects models, heterogeneity quantification (I²), forest plot construction, and funnel plot assessment for publication bias.
Longitudinal & Panel Data
Analyzing data collected over multiple time points from the same subjects. GEE models, mixed-effects models, handling missing data through multiple imputation, and time-varying covariate analysis.
Medical Exam Preparation
USMLE Step 1 Biostatistics — High-Yield Formula Reference
The USMLE biostatistics section is one of the most formula-dense parts of Step 1. These are the calculations you must be able to derive from a 2×2 table — not memorize, but derive.
The 2×2 Contingency Table
| Disease + | Disease − | Total | |
|---|---|---|---|
| Test + | TP True Positive |
FP False Positive |
TP+FP |
| Test − | FN False Negative |
TN True Negative |
FN+TN |
| Total | TP+FN | FP+TN | N |
Every USMLE biostats formula derives from these four cells.
The 2×2 table is not just a display device — it is the complete computational substrate for diagnostic test evaluation. Once you internalize what TP, FP, FN, and TN represent, every formula below is simply a ratio of these cells. Medical schools teach students to memorize these formulas, but understanding the logic of the table eliminates the need to memorize anything.
-
Sensitivity = TP / (TP + FN) — the test’s ability to detect true disease. Rule out with a high SeNsitive test (SnNOut).
-
Specificity = TN / (TN + FP) — the test’s ability to confirm the absence of disease. Rule in with a high SPecific test (SpPIn).
-
PPV = TP / (TP + FP) — the probability that a positive test truly indicates disease. PPV rises with higher prevalence.
-
NNT = 1 / ARR — the number of patients who must be treated to prevent one adverse outcome. Always paired with the Absolute Risk Reduction.
Struggling with USMLE biostatistics? Our experts can walk you through clinical vignette practice problems covering all high-yield concepts, including study bias identification, screening program evaluation, and clinical significance vs. statistical significance. Get Help Now →
Statistical Software
R vs. SAS vs. STATA — Choosing the Right Tool
One of the most common student questions is which software to use. The honest answer depends on your program, your career track, and what your instructor expects. Here is the full picture.
| Dimension | R | SAS | STATA | SPSS |
|---|---|---|---|---|
| Cost | Free & open source | Licensed (expensive) | Licensed (moderate) | Licensed (IBM) |
| Primary Use | Academia, bioinformatics, genomics | Pharma, FDA submissions, clinical trials | Epidemiology, health economics | Social sciences, basic analysis |
| Survival Analysis | survminer, survival pkg | PROC LIFETEST, PROC PHREG | sts graph, stcox | Limited |
| Mixed Models | lme4, nlme | PROC MIXED, PROC GLIMMIX | xtmixed, melogit | MIXED procedure |
| Visualization | ggplot2 (best in class) | ODS Graphics (functional) | twoway graphs | Chart builder |
| Regulatory Acceptance | Growing (FDA accepts) | Gold standard (FDA, EMA) | Accepted | Limited |
| Reproducibility | R Markdown, Quarto | Batch processing | Do files | Syntax files |
| Best For Students | MPH, PhD, bioinformatics | Clinical SAS, CDISC programs | Epi, health economics | Undergrad coursework |
We deliver native code files — R scripts, SAS programs, or STATA do-files — alongside every analysis report. For data analysis assignments, you receive both the code and annotated output interpretation.
Advanced Methods
Bayesian vs. Frequentist Biostatistics — The Debate That Shapes Modern Research
This is the gap most academic help services miss entirely. Graduate-level biostatistics increasingly requires you to understand both paradigms, and to know when each is appropriate.
The Frequentist framework — which underpins the vast majority of published clinical research — defines probability as the long-run frequency of an event across many repeated experiments. The p-value is a Frequentist construct: the probability of observing a result at least as extreme as the one obtained, assuming the null hypothesis is true. It says nothing about the probability that the null is true — a nuance that trips up students on exams and clinicians in practice.
The Bayesian framework treats probability as a degree of belief, updated by data. You begin with a prior distribution over the parameter of interest — which might encode expert knowledge from previous studies — and update it with your data to produce a posterior distribution. The posterior gives you exactly what clinicians actually want to know: given the data, what is the probability that this treatment works?
Frequentist Paradigm
- → Probability = long-run frequency
- → Output: p-values, confidence intervals
- → CI does not mean “95% chance parameter is inside”
- → Standard for FDA drug approval submissions
- → Tools: t-tests, ANOVA, Cox PH, logistic regression
Bayesian Paradigm
- → Probability = degree of belief, updated by data
- → Output: posterior distributions, credible intervals
- → 95% credible interval does mean what you think it means
- → Growing in adaptive clinical trials
- → Tools: MCMC (Stan, JAGS), BayesFactor package in R
When Your Professor Asks About This: Key Distinctions to Know
The p-value Misconception
A p < 0.05 does not mean there is a 95% probability the null hypothesis is false. It means that if the null were true, observing this result by chance would happen fewer than 5% of the time. This distinction is heavily tested in PhD qualifying exams.
Confidence vs. Credible Intervals
A 95% confidence interval means that 95% of intervals constructed this way across repeated sampling would contain the true parameter. A 95% Bayesian credible interval means there is a 95% posterior probability the parameter falls within it. Students constantly confuse these.
Adaptive Trial Design
Bayesian methods are increasingly used in adaptive clinical trials that allow pre-specified modifications to sample size, randomization ratios, or endpoint selection based on accumulating data — a flexibility the fixed Frequentist design cannot provide.
Epidemiological Methods
Epidemiology, SIR Modeling & Pandemic Statistics
The COVID-19 pandemic placed biostatistics in the public consciousness. Whether your assignment involves SIR compartmental models or vaccine efficacy analysis, the underlying statistical methods are the same ones used by the CDC and WHO.
Study Design in Epidemiology
Epidemiological study design determines both what questions can be answered and which statistical methods are valid. The three main observational designs each support different causal claims and require different analytical approaches.
-
COHORT
Follow exposed and unexposed groups forward in time. Computes Relative Risk directly. Best for common exposures. Costly and time-intensive. Landmark example: the Framingham Heart Study.
-
CASE-CTRL
Compare individuals with disease (cases) to those without (controls). Computes Odds Ratio. Efficient for rare diseases. Susceptible to recall and selection bias.
-
CROSS-SECT
Snapshot of exposure and disease at one point in time. Computes Prevalence Ratio. Cannot establish temporality. Best for prevalence estimation and generating hypotheses.
SIR Models & R₀
Compartmental models partition a population into states — Susceptible, Infectious, Recovered — and use differential equations to model disease spread over time. The Basic Reproduction Number (R₀) is the single most important quantity in this framework.
library(deSolve)
SIR <- function(t, state, params) {
with(as.list(c(state, params)), {
dS <- -beta * S * I / N
dI <- beta * S * I / N – gamma * I
dR <- gamma * I
list(c(dS, dI, dR))
})
}
# R0 = beta/gamma | Epidemic if R0 > 1
COVID-19 Biostatistics
Vaccine efficacy calculation, incidence rate ratios, age-standardized mortality rates, and “excess death” statistical analysis used by the CDC and ONS.
Agent-Based Modeling
More complex than compartmental models — simulates individual agents with heterogeneous behaviors, spatial patterns, and contact networks. Common in advanced MPH coursework.
EHR Data Analysis
Analyzing Electronic Health Records requires handling missing data, informative censoring, and confounding by indication — all advanced biostatistical competencies.
Bioinformatics & Genomics
Genomic Data Analysis — Where Biostatistics Meets Biology at Scale
High-throughput genomics generates datasets with thousands of variables and hundreds of observations, inverting the classical statistical challenge. The methods are specialized, and the multiple testing problem is severe.
Classical biostatistics operates in the realm of p < n — far more observations than variables. Genomics operates in the reverse: a GWAS study might have 500,000 SNPs (variables) measured in 5,000 participants. Testing each SNP individually at α = 0.05 would produce 25,000 false positives by chance. This is the multiple testing problem, and addressing it correctly — through Bonferroni correction, Benjamini-Hochberg false discovery rate control, or permutation-based methods — is what separates rigorous genomic analysis from naive analysis.
RNA-Seq Differential Expression
Identifying genes that are significantly up- or down-regulated between conditions. Uses DESeq2 or edgeR in R, which apply negative binomial models to handle overdispersion in count data. Multiple testing is controlled via adjusted p-values (padj) using the Benjamini-Hochberg procedure.
Genome-Wide Association Studies
Testing millions of SNPs for association with a phenotype using logistic regression with ancestry principal components as covariates. The Bonferroni threshold for genome-wide significance is p < 5×10⁻⁸. We assist with Manhattan plots, Q-Q plots, and GWAS summary statistic interpretation.
Dimensionality Reduction
High-dimensional biological data requires reducing thousands of variables to interpretable components. PCA (linear), t-SNE and UMAP (non-linear) are used for clustering cell populations in single-cell RNA-seq, identifying ancestry in GWAS, and visualizing microarray data structure.
Multiple Testing Problem
When you test thousands of hypotheses simultaneously, false positives accumulate. Bonferroni controls the Family-Wise Error Rate (FWER) conservatively. Benjamini-Hochberg controls the False Discovery Rate (FDR) — more powerful and standard in genomics. We explain which to use and why in every genomics assignment.
Evidence Synthesis
Reading & Producing Meta-Analyses
Meta-analysis sits at the top of the evidence hierarchy. Understanding how to read a forest plot, interpret I² heterogeneity, and assess publication bias through a funnel plot is an essential competency for MPH and PhD students.
Forest Plot Anatomy
A forest plot displays each study as a square (whose size reflects its statistical weight) centered on its effect estimate, with a horizontal line representing the confidence interval. The diamond at the bottom represents the pooled estimate. Studies to the left of the null line (OR/RR < 1) favor treatment; those to the right favor control.
-
I² Statistic — quantifies the proportion of total variation due to heterogeneity rather than chance. I² below 25% is low, 50–75% is moderate, above 75% is high and may call the meta-analytic pooling into question.
-
Fixed vs. Random Effects — fixed-effects models assume a single true effect across all studies; random-effects models allow the true effect to vary. Random effects is preferred when heterogeneity is present, but it does not eliminate the heterogeneity problem.
-
Funnel Plot Asymmetry — if smaller studies with negative results are missing from the plot (which they often are, because journals prefer positive results), the funnel will be asymmetric. This is evidence of publication bias. Egger’s test provides a formal test for this.
Conducting Meta-Analysis in R
library(meta)
# Run random-effects meta-analysis
ma_result <- metagen(
TE = log_OR,
seTE = se_log_OR,
studlab = study_name,
data = meta_dataset,
sm = “OR”,
method.tau = “REML”
)
# Generate forest plot
forest(ma_result, sortvar = TE)
# Assess publication bias
funnel(ma_result)
metabias(ma_result, method = “egger”)
# I² = ma_result$I2 | τ² = ma_result$tau^2
Trial Methodology
Clinical Trial Design — From Protocol to Analysis
Designing a valid clinical trial requires decisions at every stage that directly determine the statistical analysis plan. These design choices cannot be undone at the analysis stage.
Randomization
Simple randomization works for large trials but can produce imbalanced groups in small samples. Block randomization guarantees balance within each block. Stratified randomization ensures balance across important prognostic factors (age, disease severity) simultaneously.
Blinding
Single-blind (patient unaware) reduces performance bias. Double-blind (patient and clinician unaware) additionally reduces detection bias. Triple-blind (including the analyst) prevents data dredging. Not all trials can achieve blinding — surgical trials, behavioral interventions, and open-label extension phases often cannot.
Power & Sample Size
Four quantities are linked: effect size, sample size, alpha, and power. Specify any three and the fourth is determined. Convention is α = 0.05 and power = 0.80. But a drug trial aiming to detect a 10% difference in 5-year survival requires a vastly different sample than one aiming to detect a 30% difference. We perform these calculations in R (pwr, samplesize) and SAS (PROC POWER).
ITT vs. Per-Protocol vs. As-Treated — Which Analysis Do You Report?
Intention-to-Treat (ITT)
All randomized participants are analyzed in their assigned group, regardless of whether they completed the protocol. Preserves the randomization and controls Type I error. The gold standard primary analysis for superiority trials.
Per-Protocol (PP)
Analyzes only participants who completed the study per protocol. Can estimate the biological efficacy of the treatment under ideal conditions, but risks selection bias from non-random dropout. Used as a sensitivity analysis.
As-Treated
Participants are analyzed based on the treatment they actually received, not their assigned group. Useful for understanding real-world adherence patterns but breaks randomization and requires careful confounding control.
Assignment Types
Assignment Formats We Handle
Data Analysis Reports
Full statistical reporting with output tables and interpretation.
Study Protocol Design
Writing valid experimental design and methods sections.
Research Papers
Methods, Results, and Discussion sections with stats.
Code & Syntax Files
Clean, annotated R, SAS, STATA, or SPSS code.
Systematic Reviews
PRISMA-compliant data extraction and meta-analysis.
Power Analysis
Formal sample size determination with justification.
Problem Sets
Worked solutions to probability and biostats exercises.
Dissertation Chapters
Chapter 3 & 4 statistical methodology and results.
Academic Levels
Support at Every Academic Stage
From introductory descriptive statistics to complex structural equation modeling and genome-wide association studies in your dissertation, we calibrate the technical depth of every report to match your program’s expectations.
Practice Resources
Real-World Health Datasets for Practice
Biostatistics is learned by doing. These publicly available repositories are where real analyses happen — and where the most credible course assignments draw their data.
CDC WONDER
Wide-ranging online data for epidemiologic research — mortality, natality, infectious disease, and environmental health.
Access Dataset →WHO Global Health Observatory
Standardized global health indicators across 194 member states — mortality, disease burden, health systems data.
Access Dataset →Cochrane Library
The gold standard repository for systematic reviews and clinical trial reports, including CENTRAL trial registration data.
Visit Library →NCBI GEO & dbGaP
Public genomics data repository for microarray, RNA-seq, and GWAS datasets. The primary source for bioinformatics assignments.
Access Dataset →ClinicalTrials.gov
Registry and results database of publicly and privately funded clinical trials worldwide. Essential for literature reviews and study design assignments.
Browse Trials →SEER Cancer Statistics
NIH/NCI Surveillance, Epidemiology, and End Results program — the definitive source for survival analysis in oncology coursework.
Access Dataset →Service Quality
Service Guarantees
Statistical Accuracy
All test assumptions, p-values, and model outputs are independently verified. Wrong assumptions, wrong results — we catch both.
Native Code Files
You receive the actual R scripts, SAS programs, or STATA do-files — not screenshots of output. Every line is commented.
Full Confidentiality
Your dataset and research findings are your intellectual property. Secure file transfer, no third-party sharing, NDA available.
On-Time Delivery
Deadlines are absolute. From 24-hour rush deliveries to multi-week dissertation projects, we hit every milestone.
Career Context
Where Biostatistics Careers Lead
Understanding your career trajectory helps you prioritize which methods and software to master. These are the primary employment sectors for biostatistics graduates.
Pharma & Biotech
Drug development, regulatory submissions, and Phase I–III trial analysis. SAS is the dominant software here.
CROs
Contract Research Organizations. Supports multiple sponsors simultaneously across therapeutic areas.
Government (FDA, CDC, NIH)
Regulatory science, public health surveillance, and large-scale epidemiological research programs.
Academia
Teaching, collaborative research, grant writing (NIH/NCI), and producing primary biostatistics methodology.
Process
How to Get Your Biostatistics Assignment Done
Upload Your Assignment
Share your dataset (CSV, Excel, SAS .sas7bdat) and your research question, rubric, or assignment prompt. The more context, the better the output.
Select Subject & Deadline
Choose Biostatistics or Public Health. Set your deadline. A pricing confirmation is sent immediately — no hidden costs after you proceed.
Expert Analysis Begins
A PhD biostatistician is assigned. They select appropriate methods, verify assumptions, run the analysis, and draft the interpreted report.
Receive Report & Code
Download a fully interpreted report with figures, tables, and your native code files. Free revision if any output does not match requirements.
Student Reviews
What Researchers & Students Say
“The survival analysis report was outstanding. The Cox model was run correctly with the PH assumption tested — something my previous tutor had never checked — and the interpretation was clinical, not just statistical. It directly improved my dissertation defense.”
“I was completely lost with SAS programming for my clinical trials methods class. The code delivered was clean, every step was commented, and the TLGs generated were exactly the format my instructor required. Ran without a single error.”
“The USMLE biostats practice set they worked through with me made the difference on Step 1. The 2×2 table explanations finally made everything click — I stopped memorizing and started deriving. Scored in the 90th percentile on that section.”
“My meta-analysis for the systematic review course was handled precisely — fixed vs. random effects decision was justified, I² was properly interpreted, and the funnel plot asymmetry discussion used Egger’s test. Exactly what the rubric required.”
FAQ
Frequently Asked Questions
Can you analyze clinical trial data using SAS?
Yes. Our experts are proficient in SAS for clinical data management, including PROC LIFETEST for survival analysis, PROC PHREG for Cox models, PROC MIXED for longitudinal data, and PROC REPORT for generating TLGs (Tables, Listings, and Graphs) in FDA-compliant formats. We can also work with CDISC-structured datasets (SDTM and ADaM).
Do you help with Kaplan-Meier curves and survival analysis?
Absolutely. We generate Kaplan-Meier plots with at-risk tables, conduct Log-Rank tests to compare survival curves between groups, fit Cox Proportional Hazards models, and formally test the PH assumption using Schoenfeld residuals (cox.zph in R, ASSESS statement in SAS). Output includes publication-quality figures and full interpretation of hazard ratios and confidence intervals.
What is the difference between Bayesian and Frequentist approaches, and do you support both?
Frequentist statistics (t-tests, ANOVA, Cox PH, logistic regression) uses p-values and confidence intervals based on the long-run frequency of events. Bayesian statistics incorporates prior beliefs through prior distributions and updates them with data to produce posterior probabilities and credible intervals. We support both frameworks — standard Frequentist methods for most coursework, and Bayesian implementations using R packages (brms, BayesFactor, rstan) or PROC MCMC in SAS for advanced graduate work.
Can you help with genomics and RNA-seq differential expression analysis?
Yes. We assist with RNA-seq differential expression using DESeq2 and edgeR in R, microarray analysis using limma, GWAS interpretation and visualization (Manhattan plots, Q-Q plots), principal component analysis for ancestry correction, and multiple testing correction using Bonferroni or Benjamini-Hochberg FDR procedures. For bioinformatics-specific pipelines, we work with Bioconductor packages. See our biology assignment help page for more.
Can you determine sample size for my study design?
Yes. We perform formal power analysis using R (pwr, powerSurvEpi packages), SAS (PROC POWER), or G*Power for a wide range of study designs: two-sample t-tests, chi-square tests, logistic regression, survival analysis (log-rank), one-way ANOVA, equivalence/non-inferiority trials, and paired designs. We provide a fully written justification section for your methods chapter.
Do you help with USMLE biostatistics preparation?
Yes. We provide worked examples and explanations covering all high-yield USMLE Step 1 biostatistics concepts: 2×2 table derivations, sensitivity, specificity, PPV, NPV, likelihood ratios, NNT, attributable risk, relative risk, odds ratios, confidence intervals, hypothesis testing, bias types (selection, recall, lead-time, length-time), and study design evaluation. We can work through clinical vignette practice questions with you.
Is my data and research information kept confidential?
Yes, strictly. Your dataset, research question, and findings are your intellectual property. We use secure file transfer protocols, do not share data with third parties, do not retain data after project completion, and can sign a Non-Disclosure Agreement for sensitive research projects. Payment is processed through encrypted gateways.
What file formats do you work with for datasets?
We accept all common statistical data formats: CSV, Excel (.xlsx, .xls), SAS datasets (.sas7bdat), STATA datasets (.dta), SPSS files (.sav), R data files (.RData, .rds), and plain text (.txt). For genomics work, we also handle VCF files, BED files, and count matrices from RNA-seq pipelines.
Related Services
Explore Related Academic Services
Public Health Help
Health policy, epidemiology assignments, and global health analysis.
Statistics Help
General statistics across all disciplines and software platforms.
Nursing Assignment Help
EBP, PICOT, SOAP notes, and clinical data interpretation.
Data Analysis Help
Quantitative research, SPSS, R, and Python-based analysis.
Ready to Turn Your Data Into Evidence?
Upload your dataset and assignment brief. A PhD biostatistician will review it within the hour and confirm your quote — no commitment required until you approve.
Start My Analysis →